DTT Journal & Abstracts

All abstracts accepted for the Breakthrough T1D Clinical & Research Congress 2026 will be published in Diabetes Technology & Therapeutics (DTT), the official journal of CRC 2026, provided that the presenting author has completed registration for the Congress. The abstracts will be available online from December 14, 2026.

Diabetes Technology & Therapeutics, led by Editor-in-Chief Satish K. Garg, MD, is the only peer-reviewed journal providing information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes.

This leading international journal delivers practical information and comprehensive coverage of the latest technologies and therapeutics in the field. Each issue highlights new pharmacological and device developments to optimize patient care.